• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Nvidia offers EU concessions over $54 billion Arm deal

October 6, 2021 by David Barret Leave a Comment

October 6, 2021

By Foo Yun Chee

BRUSSELS (Reuters) -Nvidia has offered concessions in a bid to secure EU antitrust approval for its $54 billion acquisition of British chip designer Arm, a European Commission filing showed on Wednesday.

The deal announced by world’s biggest maker of graphics and AI chips last year has sparked concerns in the semiconductor industry over whether Arm could remain a neutral player licensing intellectual property to customers and rivals.

The EU competition enforcer, which did not provide details of the concessions in line with its policy, set an Oct. 27 deadline for its decision.

It will now seek feedback from rivals and customers before deciding whether to accept the concessions, demand more or open a four-month long investigation.

Nvidia has said it would maintain Arm as a neutral technology supplier as it aims to allay concerns from customers such as Qualcomm Inc, Samsung Electronics Co Ltd and Apple Inc.

Arm customers Broadcom, MediaTek and Marvell are supporters of the deal.

Arm, owned by Japan’s SoftBank Group Corp, is a major player in global semiconductors. Its designs power nearly every smartphone and millions of other devices.

(Reporting by Foo Yun Chee; editing by Louise Heavens and Jason Neely)

Source Link Nvidia offers EU concessions over $54 billion Arm deal

David Barret
David Barret

Related posts:

  1. BP Ventures invests $11.9M in in-car payments provider Ryd to support expansion
  2. ‘The Wire’ actor Michael K. Williams found dead in apartment – NYPD
  3. Turkish President Erdogan says to meet Greek PM in New York
  4. Exclusive-White House, top Democrats reach deal in budget bill on carbon capture credit -sources

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Revolutionary Drug That’s “Closest Thing” To HIV Vaccine Gets FDA Approval
  • This Is Your Brain On ChatGPT: Lower Neural Interconnectivity And “Soulless” Work
  • In November 2026, A Human-Made Object Will Reach A Light-Day From Earth For First Time In History
  • Alan Turing Masterpieces “Almost Shredded” By Owners Fetch $625,000 At Auction
  • Salton Sea: California’s Largest And Most Polluted Lake Is Even More Toxic Than Thought
  • Sharks Follow A Fundamental Law Of Geometry, And That’s A Really Big Deal
  • “Swarm Intelligence” Sees Longhorn Crazy Ants Clear The Path For Nestmates
  • Cave Remains Reveal Earliest Evidence Of Ice Age Indigenous Australians At High Altitude
  • Scientists Have Finally Identified A Denisovan Skull – It’s Been Hiding In Plain Sight Since 1933
  • Thought Horns Were Just For Cows? This Striking Triple-Horned Chameleon Proves Otherwise
  • Elon Musk’s Starship Doesn’t Even Have To Fly To Explode Now
  • How Do We Know The Bible’s Forbidden Fruit Was An Apple?
  • Your Genetic Ancestry Is Probably Not What You Think It Is
  • Researchers Use Bubbles To Encode And Store Messages In Ice, And Read Them Back From Photographs
  • Analemmas And The Equation Of Time: Why The Path Of The Sun Traces Out An 8 On Earth
  • Positive Nihilism: Is Meaninglessness The Key To Happiness?
  • Feast Your Eyes On The Most Detailed 1,000-Color Image Of A Nearby Galaxy
  • Engineering YouTuber Weighs An Airbus A320 Plane Whilst It Is Still Flying
  • Australian Moth Is First-Known Invertebrate To Navigate By Stars On Epic 1,000-Kilometer Migration
  • Losing Two Legs Doesn’t Slow Tarantulas Down Or Make Them More Unstable
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version